{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:08:08Z","timestamp":1793333288309,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lfs.2025.123981","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:15:02Z","timestamp":1758464102000},"page":"123981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics"],"prefix":"10.1016","volume":"381","author":[{"given":"Amin","family":"Mohsenzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Pourasgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeganeh","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Firoozbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mohsenzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0010","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0015","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2025.123981_bb0020","doi-asserted-by":"crossref","first-page":"971376","DOI":"10.3389\/fcvm.2022.971376","article-title":"Causal associations between gut microbiome and cardiovascular disease: a Mendelian randomization study","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.lfs.2025.123981_bb0030","first-page":"e30119","article-title":"A systematic review of major cardiovascular risk factors: a growing global health concern","volume":"14","author":"Adhikary","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.lfs.2025.123981_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109087","article-title":"Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship","volume":"24","author":"Nesci","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/biomedicines13020343","article-title":"Short-chain fatty acids and their metabolic interactions in heart failure","volume":"13","author":"Chulenbayeva","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2025.123981_bb0045","doi-asserted-by":"crossref","first-page":"1445113","DOI":"10.3389\/fpubh.2024.1445113","article-title":"A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers","volume":"12","author":"Kameri","year":"2025","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/biology14040332","article-title":"Human milk microbiome from polish women giving birth via vaginal delivery\u2014pilot study","volume":"14","author":"Chrustek","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.lfs.2025.123981_bb0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3389\/fmicb.2019.01305","article-title":"Role of the microbiota in the modulation of vaccine immune responses","volume":"10","author":"Ciabattini","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123981_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41435-021-00126-8","article-title":"The aging gut microbiome and its impact on host immunity","volume":"22","author":"Bosco","year":"2021","journal-title":"Genes Immun."},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","article-title":"The interplay between diet and the gut microbiome: implications for health and disease","volume":"22","author":"Ross","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123981_bb0070","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2020-323715","article-title":"Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health","volume":"71","author":"Jardon","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2025.123981_bb0075","article-title":"Effect of antibiotic exposure on upper respiratory tract bacterial flora","volume":"28","author":"Korkmaz","year":"2022","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.lfs.2025.123981_bb0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/v13081567","article-title":"Gut microbiome changes associated with epithelial barrier damage and systemic inflammation during antiretroviral therapy of chronic SIV infection","volume":"13","author":"Tanes","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","article-title":"Intestinal barrier function: molecular regulation and disease pathogenesis","volume":"124","author":"Groschwitz","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123981_bb0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/prd.12433","article-title":"Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia","volume":"89","author":"Pussinen","year":"2022","journal-title":"Periodontol. 2000"},{"issue":"19","key":"10.1016\/j.lfs.2025.123981_bb0110","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2016.02.063","article-title":"Association between peptidoglycan recognition protein-1 and incident atherosclerotic cardiovascular disease events: the Dallas heart study","volume":"67","author":"Brownell","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2025.123981_bb0120","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.lfs.2025.123981_bb0125","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.3390\/ijms25179735","article-title":"Neutrophil biomarkers can predict cardiotoxicity of anthracyclines in breast cancer","volume":"25","author":"Todorova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123981_bb0135","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/ATVBAHA.118.311023","article-title":"Gut microbiota\u2013dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes","volume":"38","author":"Haghikia","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-physiol-031522-092054","article-title":"The role of the gut microbiota in the relationship between diet and human health","volume":"85","author":"Perler","year":"2023","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4049\/jimmunol.1601247","article-title":"Microbiome-modulated metabolites at the interface of host immunity","volume":"198","author":"Blacher","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu11010051","article-title":"Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors","volume":"11","author":"De la Cuesta-Zuluaga","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.lfs.2025.123981_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0165","first-page":"3164","article-title":"Role of the gut bacteria-derived metabolite phenylacetylglutamine in health and diseases","volume":"9","author":"Krishnamoorthy","year":"2024","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0170","doi-asserted-by":"crossref","first-page":"101492","DOI":"10.1016\/j.beem.2021.101492","article-title":"Gut microbiota and their metabolites in cardiovascular disease","volume":"35","author":"Jansen","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/joim.13653","article-title":"Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients","volume":"294","author":"Wei","year":"2023","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.lfs.2025.123981_bb0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","article-title":"Gut microbiota derived metabolites in cardiovascular health and disease","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"issue":"8","key":"10.1016\/j.lfs.2025.123981_bb0195","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/nu9080859","article-title":"Bridging the gap between gut microbial dysbiosis and cardiovascular diseases","volume":"9","author":"Lau","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0205","first-page":"261","article-title":"The role of bile acids in cardiovascular diseases: from mechanisms to clinical implications","volume":"14","author":"Zhang","year":"2023","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0210","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/j.2040-4603.2021.tb00166.x","article-title":"The calcium signaling mechanisms in arterial smooth muscle and endothelial cells","volume":"11","author":"Ottolini","year":"2021","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0215","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1159\/000478683","article-title":"Caveolae depletion contributes to vasorelaxant effects of chenodeoxycholic acid","volume":"42","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0220","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1002\/cph4.70024","article-title":"Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease","volume":"15","author":"Kondapalli","year":"2025","journal-title":"Compr. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123981_bb0230","doi-asserted-by":"crossref","first-page":"1406220","DOI":"10.3389\/fcvm.2024.1406220","article-title":"The interaction between oral microbiota and gut microbiota in atherosclerosis","volume":"11","author":"Li","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2025.123981_bb0235","doi-asserted-by":"crossref","first-page":"1514726","DOI":"10.3389\/fimmu.2025.1514726","article-title":"Microbiota-derived extracellular vesicles: current knowledge, gaps, and challenges in precision nutrition","volume":"16","author":"Marquez-Paradas","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0240","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123981_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2018.11.038","article-title":"The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease","volume":"284","author":"Liu","year":"2019","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.lfs.2025.123981_bb0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physiolgenomics.00070.2018","article-title":"Dysbiosis signatures of gut microbiota in coronary artery disease","volume":"50","author":"Zhu","year":"2018","journal-title":"Physiol. Genomics"},{"issue":"23","key":"10.1016\/j.lfs.2025.123981_bb0255","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.3390\/jcm12237212","article-title":"Epicardial and pericoronary adipose tissue, coronary inflammation, and acute coronary syndromes","volume":"12","author":"Napoli","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0260","doi-asserted-by":"crossref","first-page":"e0180717","DOI":"10.1371\/journal.pone.0180717","article-title":"The changes of gut microbiota after acute myocardial infarction in rats","volume":"12","author":"Wu","year":"2017","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0265","first-page":"1","article-title":"Probiotic Lactobacillus plantarum may reduce cardiovascular risk: An experimental study","volume":"17","author":"Neverovskyi","year":"2021","journal-title":"ARYA Atheroscler"},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0270","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","article-title":"Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat","volume":"7","author":"Gan","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.lfs.2025.123981_bb0275","first-page":"H1227","article-title":"Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease","volume":"319","author":"Lewis","year":"2020","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0280","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.121.318065","article-title":"The gut microbiome in hypertension","volume":"128","author":"Avery","year":"2021","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0285","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/ijms24021377","article-title":"Does the composition of gut microbiota affect hypertension? Molecular mechanisms involved in increasing blood pressure","volume":"24","author":"Tokarek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123981_bb0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2017.00381","article-title":"Alterations of the gut microbiome in hypertension","volume":"7","author":"Yan","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0295","doi-asserted-by":"crossref","first-page":"2195135","DOI":"10.1080\/10641963.2023.2195135","article-title":"Gut microbiota and hypertension: association, mechanisms and treatment","volume":"45","author":"Yang","year":"2023","journal-title":"Clin. Exp. Hypertens."},{"issue":"8","key":"10.1016\/j.lfs.2025.123981_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081158","article-title":"The implication of the gut microbiome in heart failure","volume":"12","author":"Lupu","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.lfs.2025.123981_bb0305","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections between microbiome and heart failure: revisiting the gut hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.lfs.2025.123981_bb0310","series-title":"The Effects of Gut-Derived Trimethylamine N-Oxide (TMAO) on the Pathogenesis of Heart Failure","author":"Le Organ","year":"2017"},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0315","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.06.1179","article-title":"Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia","volume":"64","author":"Sandek","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123981_bb0320","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","article-title":"Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts","volume":"71","author":"Kummen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0325","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/molecules26041172","article-title":"Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases","volume":"26","author":"Oniszczuk","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2025.123981_bb0330","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2017.00139","article-title":"Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2025.123981_bb0335","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fphys.2019.00866","article-title":"Trimethylamine n-oxide exacerbates cardiac fibrosis via activating the NLRP3 inflammasome","volume":"10","author":"Li","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2025.123981_bb0340","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fphys.2017.00944","article-title":"Trimethylamine N-oxide supplementation abolishes the cardioprotective effects of voluntary exercise in mice fed a western diet","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123981_bb0345","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/STROKEAHA.121.036800","article-title":"Gut microbiota and their metabolites in stroke: a double-edged sword","volume":"53","author":"Peh","year":"2022","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0350","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/nep3.44","article-title":"Role of gut microbiota in ischemic stroke: a narrative review of human and animal studies","volume":"2","author":"Chen","year":"2024","journal-title":"Neuroprotection"},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0355","article-title":"Gut microbiota and stroke","volume":"23","author":"Tan","year":"2020","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071239","article-title":"The influence of gut dysbiosis in the pathogenesis and management of ischemic stroke","volume":"11","author":"Chidambaram","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0365","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002699","article-title":"Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack","volume":"4","author":"Yin","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0370","doi-asserted-by":"crossref","first-page":"e0171521","DOI":"10.1371\/journal.pone.0171521","article-title":"Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke","volume":"12","author":"Yamashiro","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/atm-22-6029","article-title":"Modulation of the intestinal bacterial flora: a viable strategy to alleviate acute mesenteric ischemia?","volume":"11","author":"S\u00f8fteland","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.lfs.2025.123981_bb0380","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/ATVBAHA.120.314491","article-title":"Gut microbiota restricts NETosis in acute mesenteric ischemia-reperfusion injury","volume":"40","author":"Ascher","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0385","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3164\/jcbn.17-137","article-title":"Microbiome and intestinal ischemia\/reperfusion injury","volume":"63","author":"Nadatani","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"19","key":"10.1016\/j.lfs.2025.123981_bb0390","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.3390\/ijms251910595","article-title":"Non-alcoholic fatty liver disease and coronary artery disease: a bidirectional association based on endothelial dysfunction","volume":"25","author":"Ktenopoulos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0395","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3748\/wjg.v23.i7.1241","article-title":"Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms","volume":"23","author":"Ponziani","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073698","article-title":"The contribution of gut microbiota and endothelial dysfunction in the development of arterial hypertension in animal models and in humans","volume":"23","author":"Maiuolo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.123981_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065806","article-title":"Modulation of endothelial function by TMAO, a gut microbiota-derived metabolite","volume":"24","author":"Querio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123981_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104583","article-title":"Gut microbiome and atrial fibrillation—results from a large population-based study","volume":"91","author":"Palmu","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.lfs.2025.123981_bb0415","article-title":"The critical role of gut microbiota in obesity","volume":"13\u20132022","author":"Cheng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2025.123981_bb0420","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.2147\/DMSO.S432344","article-title":"The characteristics, mechanisms and therapeutics: exploring the role of gut microbiota in obesity","volume":"16","author":"Zhuang","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0425","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","article-title":"Gut microbiome lipid metabolism and its impact on host physiology","volume":"31","author":"Brown","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0430","doi-asserted-by":"crossref","first-page":"100376","DOI":"10.4239\/wjd.v16.i1.100376","article-title":"Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy","volume":"16","author":"Wen","year":"2025","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.lfs.2025.123981_bb0435","article-title":"Gut microbiota: an important player in type 2 diabetes mellitus","volume":"12\u20132022","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0440","doi-asserted-by":"crossref","first-page":"5110276","DOI":"10.1155\/2021\/5110276","article-title":"Gut microbiota and type 2 diabetes mellitus: association, mechanism, and translational applications","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"12","key":"10.1016\/j.lfs.2025.123981_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122227","article-title":"The role of the gut microbiota in lipid and lipoprotein metabolism","volume":"8","author":"Yu","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0450","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","article-title":"Gut microbiome lipid metabolism and its impact on host physiology","volume":"31","author":"Brown","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.lfs.2025.123981_bb0455","doi-asserted-by":"crossref","first-page":"e18991","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2025.123981_bb0460","article-title":"The human microbiome in chronic kidney disease: a double-edged sword","volume":"8\u20132021","author":"Wehedy","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.lfs.2025.123981_bb0465","article-title":"The association between the dietary index for gut microbiota and its components with cardiovascular disease risk: a cross-sectional study based on NHANES","volume":"12\u20132025","author":"Na","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.lfs.2025.123981_bb0470","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.csbj.2022.03.028","article-title":"Diet-gut microbiota interactions on cardiovascular disease","volume":"20","author":"Zhang","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.lfs.2025.123981_bb0475","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/nu17060948","article-title":"Gut microbiota modulation through Mediterranean diet foods: implications for human health","volume":"17","author":"Perrone","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2025.123981_bb0480","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ijms26031335","article-title":"Health-improving effects of polyphenols on the human intestinal microbiota: a review","volume":"26","author":"Nemzer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123981_bb0485","doi-asserted-by":"crossref","first-page":"1342787","DOI":"10.3389\/fnut.2024.1342787","article-title":"The impact of intermittent fasting on gut microbiota: a systematic review of human studies","volume":"11","author":"Paukkonen","year":"2024","journal-title":"Front. Nutr."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0490","first-page":"e37567","article-title":"The effects of probiotics on cholesterol levels in patients with metabolic syndrome: a systematic review","volume":"15","author":"Momin","year":"2023","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0495","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1002\/fsn3.4142","article-title":"The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: a review","volume":"12","author":"Ghanbari","year":"2024","journal-title":"Food Sci. Nutr."},{"issue":"4","key":"10.1016\/j.lfs.2025.123981_bb0500","article-title":"Rifaximin alleviates endotoxemia with decreased serum levels of soluble CD163 and mannose receptor and partial modification of gut microbiota in cirrhotic patients","volume":"9","author":"Kaji","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/j.lfs.2025.123981_bb0505","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.3390\/biomedicines10112742","article-title":"Current trends and challenges of fecal microbiota transplantation\u2014an easy method that works for all?","volume":"10","author":"Almeida","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.lfs.2025.123981_bb0510","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"Supplement_3","key":"10.1016\/j.lfs.2025.123981_bb0515","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiaa779","article-title":"Opportunities and challenges in development of live biotherapeutic products to fight infections","volume":"223","author":"Ducarmon","year":"2021","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.lfs.2025.123981_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093041","article-title":"Maternal 3,3-dimethyl-1-butanol therapy protects adult male rat offspring against hypertension programmed by perinatal TCDD exposure","volume":"13","author":"Hsu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2025.123981_bb0525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.phrs.2018.11.042","article-title":"Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition","volume":"139","author":"Hu","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jth.14331","article-title":"Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?","volume":"17","author":"van Mens","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"14","key":"10.1016\/j.lfs.2025.123981_bb0535","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/cvr\/cvae128","article-title":"Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease","volume":"120","author":"Pham","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.lfs.2025.123981_bb0540","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.tem.2024.03.007","article-title":"Opportunities and challenges in phage therapy for cardiometabolic diseases","volume":"35","author":"Wortelboer","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2025.123981_bb0545","doi-asserted-by":"crossref","first-page":"2323237","DOI":"10.1080\/19490976.2024.2323237","article-title":"Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation","volume":"16","author":"Shi","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.lfs.2025.123981_bb0550","article-title":"The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation","volume":"12\u20132022","author":"Rahman","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123981_bb0555","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1139\/cjm-2020-0043","article-title":"Understanding connections and roles of gut microbiome in cardiovascular diseases","volume":"67","author":"Rajendiran","year":"2021","journal-title":"Can. J. Microbiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:22:46Z","timestamp":1762572166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525006174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":111,"alternative-id":["S0024320525006174"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123981","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123981"}}